1. Home
  2. HAE vs DFH Comparison

HAE vs DFH Comparison

Compare HAE & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • DFH
  • Stock Information
  • Founded
  • HAE 1971
  • DFH 2008
  • Country
  • HAE United States
  • DFH United States
  • Employees
  • HAE N/A
  • DFH N/A
  • Industry
  • HAE Medical/Dental Instruments
  • DFH Homebuilding
  • Sector
  • HAE Health Care
  • DFH Consumer Discretionary
  • Exchange
  • HAE Nasdaq
  • DFH Nasdaq
  • Market Cap
  • HAE 2.4B
  • DFH 2.2B
  • IPO Year
  • HAE 1991
  • DFH 2021
  • Fundamental
  • Price
  • HAE $51.31
  • DFH $23.19
  • Analyst Decision
  • HAE Buy
  • DFH Hold
  • Analyst Count
  • HAE 8
  • DFH 1
  • Target Price
  • HAE $76.88
  • DFH $26.00
  • AVG Volume (30 Days)
  • HAE 711.7K
  • DFH 289.1K
  • Earning Date
  • HAE 11-06-2025
  • DFH 10-31-2025
  • Dividend Yield
  • HAE N/A
  • DFH N/A
  • EPS Growth
  • HAE 46.89
  • DFH 0.34
  • EPS
  • HAE 3.28
  • DFH 3.08
  • Revenue
  • HAE $1,346,046,000.00
  • DFH $4,708,435,000.00
  • Revenue This Year
  • HAE N/A
  • DFH $6.07
  • Revenue Next Year
  • HAE $6.42
  • DFH $1.25
  • P/E Ratio
  • HAE $15.66
  • DFH $7.48
  • Revenue Growth
  • HAE 0.91
  • DFH 20.19
  • 52 Week Low
  • HAE $47.32
  • DFH $19.65
  • 52 Week High
  • HAE $94.99
  • DFH $34.43
  • Technical
  • Relative Strength Index (RSI)
  • HAE 51.54
  • DFH 37.23
  • Support Level
  • HAE $48.55
  • DFH $22.20
  • Resistance Level
  • HAE $51.89
  • DFH $23.67
  • Average True Range (ATR)
  • HAE 1.43
  • DFH 0.95
  • MACD
  • HAE 0.56
  • DFH -0.06
  • Stochastic Oscillator
  • HAE 85.48
  • DFH 22.94

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.

Share on Social Networks: